Loading…

Improvement in Treatment Outcome and Identification of a New Prognostic Parameter in Down Syndrome Acute Myeloid Leukemia (DS-AML): Results of the Children’s Oncology Group (COG) Phase III AAML0431 Trial

Background: DS-AML patients (

Saved in:

Bibliographic Details
Published in:	Blood 2014-12, Vol.124 (21), p.278-278
Main Authors:	Taub, Jeffrey W, Berman, Jason N, Hitzler, Johann K., Sorrell, April D., Lacayo, Norman J., Mast, Kelley, Head, David R., Raimondi, Susana C., Hirsch, Betsy A., Gerbing, Robert B., Alonzo, Todd A., Campana, Dario, Coustan-Smith, Elaine, Mathew, Prasad, Gamis, Alan S.
Format:	Article
Language:	English
Citations:	Items that cite this one
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!